Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Influence of IL-28B serum level and gene polymorphism in a sample of Iraqi patients with ankylosing spondylitis
- Abdulmalek H.W. , et al.
2. Assessment of new e2 protein domain interaction with pkr protein to control ifn signaling
- Dehghani B. , et al.
3. Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis C
- Hashempour T. , et al.
4. Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran
- Moghimi M. , et al.
5. The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin
- Kalantari H. , et al.
6. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients
- Echeverría N. , et al.
7. Hepatitis C Virus-Infected Responders and Relapsers to Treatment Show Similar Genetic Profiles of IL28B and IL10 Single Nucleotide Polymorphisms
- De Souza S. , et al.
8. Interleukin 28B genetic polymorphism and spontaneous recovery from hepatitis B virus infection in an Iranian Azeri population
- Baghbani J.M. , et al.
9. Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
- Keshvari M. , et al.
10. sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy
- Jud S. , et al.
11. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients
- Alborzi A. , et al.
12. The role of polymorphisms near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy
- Miri S.M. , et al.
13. Genetic variation in interleukin-28B and response to Peg-IFNα-2a/RBV combination therapy in patients with hepatitis C virus infection
- Bokharaei-Salim F. , et al.
14. The effect of IL28B gene polymorphism on treatment response in iranian patients with hepatitis C virus infection
- Zare F. , et al.
15. The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in iranian patients with chronic hepatitis C
- Kadjbaf D. , et al.
16. The association of substitutions in the hepatitis C virus subtype 1b core gene and IL28B polymorphisms with the response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients
- Bokharaei-Salim F. , et al.
17. The ITPA and C20orf194 polymorphisms and hematological changes during treatment with pegylated-interferon plus ribavirin in patients with Chronic Hepatitis C
- Pouryasin M. , et al.
18. The role of polymorphisms near the IL28B gene on response to peg-interferon and ribavirin in thalassemic patients with Hepatitis C
- Behnava B. , et al.
19. Lack of association between interleukin 28B gene polymorphisms (rs8099917G/T, rs12979860 C/T) and susceptibility to chronic hepatitis C virus infection, Tehran, Iran
- Karkhane M. , et al.
20. Interferon-λpolymorphisms and response to pegylated interferon in Iranian hepatitis C patients
- Haj-sheykholeslami A. , et al.
21. Efficacy of 24-week pegylated interferon alpha and ribavirin combination therapy in highly selected patients infected with hepatitis C virus genotype 1
- Sharafi H. , et al.
22. Impact of the il-10 promoter gene polymorphisms in the severity of chronic hepatitis b infection
- Baghi S.G. , et al.
23. Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city
- Mousavi Nasab S.D. , et al.